Navigation Links
Varian Medical Systems Selected by Leading Russian Development Foundations to Take Part in High-Profile Supplier Event
Date:11/2/2012

MOSCOW, Nov. 2, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), the world leader in radiotherapy equipment and software for treating cancer, is reinforcing its commitment to the Russian Federation by actively seeking Russia-based suppliers and local R&D collaborations. At this week's Open Innovations Forum in Moscow, Varian is holding a joint supplier conference with local organizations the Skolkovo and Rusnano Foundations to explain its strategy for the Russian market and seek local partners.

"The Russian government is determined to improve the access of its people to modern, advanced radiotherapy equipment and as the market and technology leader in this field Varian wants to support this initiative," says Kolleen Kennedy, head of Varian's global Oncology Systems business. "We are delighted to have been selected by the Skolkovo and Rusnano foundations to work with them on this first such event to support the country's program of greater healthcare access, industrial modernization, R&D, and in-country investment.  We want to work together and be present to leverage Russia's technological strengths into a global network of supply and development."

The Skolkovo Foundation is a not-for-profit, government-funded organization that was launched in 2010 as part of the Kremlin's efforts to transform Russia into a modern, post-industrial economy by creating an innovative ecosystem that is intended as Russia's answer to Silicon Valley. Among the most prestigious planned projects is the Skolkovo Institute of Science and Technology, a major university campus that Switzerland's Herzog & de Meuron is designing in collaboration with the Massachusetts Institute of Technology.

"This project is a unique one for us and for Russian business practices," said Denis Kovalevich, executive director of the Skolkovo Foundation's Nuclear Technology Cluster. "Together with Varian Medical Systems and our Russian partners, we are trying to implement a new model of localization for our country. While we don't consider an assembly of a final product in Russia as a major goal of the project, we hope that Russian manufacturers of components, engineering and research centers will become a part of Varian's global supply chain. As a result, Russian companies would expand supplies of equipment and R&D services not only within Russia, but globally. For all of us it should be a win-win strategy on the basis of Varian's high quality standards and the extreme competence of Russian companies and staff."

The Rusnano Foundation for Infrastructure and Educational Programs (FIEP) develops and supports Russia's integration with global leaders. The foundation intends to help potential local suppliers to establish the necessary production and technical infrastructure and implement international quality standards that meet the requirements of Varian Medical Systems. "Well-developed infrastructure is an essential base for interaction of a major world player with local suppliers. Their products often require additional finishing work using expensive equipment to meet international standards. Nanotechnology centers created with the help of the Fund is an ideal place to perform these operations," said FIEP deputy CEO Ruslan Titov.

Supplier Conference

A series of conferences, of which this is the first, are being organized jointly by the Skolkovo and Rusnano Foundations to enable radiation oncology suppliers to outline their local strategy and stage practical events focused on the development of partnerships with Russian companies. Varian is delivering a presentation about its structure and products and meeting with the heads of Russian companies to identify potential suppliers of components and materials for both medical and industrial systems manufactured by the company.

Varian in Russian Federation

More than 50 Varian medical linear accelerators are installed in Russian cancer clinics and the company currently supplies approximately 20 new treatment systems each year to radiotherapy departments in the country.  The company operates an office in Moscow employing 24 people and Varian intends to expand geographical coverage across the Russian Federation in the near future.  

"We want to build on our great track record in this vast country and demonstrate our commitment to enabling more cancer patients in Russia to gain access to the most modern cancer treatments available," says Sergey Popov, Varian's country director. "Working more closely with local suppliers and establishing local R&D collaborations are the next logical steps in helping to achieve this. We are extremely excited about being selected by the prestigious Skolkovo and Rusnano Foundations to take part in this first such radiotherapy supplier conference."

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications.  Varian Medical Systems employs approximately 6,100 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on https://twitter.com/VarianMedSys


'/>"/>
SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. RayBiotech, Inc. and Abeome Corporation Announce an Agreement Related to Novel Research Products for Ovarian Cancer
2. American Board of Radiology Foundation receives grant from Varian Medical Systems for national brachytherapy registry
3. Varian Medical Systems to Proceed with Year End Review and Webcast for Investors at ASTRO Meeting in Boston
4. Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2012
5. Varian Medical Systems Signs Purchase Agreement with Advanced Particle Therapy LLC to Supply Technology for the Georgia Proton Treatment Center to be operated by Emory Healthcare
6. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
7. Institut Curie Acquires Four Advanced Radiotherapy Treatment Systems Including Three Varian TrueBeam Devices
8. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
9. Varian Medical Systems Establishes Subsidiary in South Korea
10. Cancer Patients in Central Vietnam to Gain Access to Advanced Radiotherapy Treatments Using Technology from Varian Medical Systems
11. Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology:
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set ... one video to the next without having to set a single keyframe in ... to enhance your video production. , TransDark features dynamic transitions that momentarily splits the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... An April 24th article on ... stunning 180 pounds with the help of a weight loss surgery. The woman, declaring “I ... skin that have been left following her dramatic weight loss. Dr. Feiz & Associates notes ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Beginning in 2017, ... their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure that ... the formula in the following ways:, , Removal of the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):